Trexquant Investment LP Sangamo Therapeutics, Inc Transaction History

Trexquant Investment LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$9.23 - $18.18 $1.37 Million - $2.7 Million	-148,502 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$9.38 - $12.48 $900,245 - $1.2 Million	95,975 Added 182.72%	148,502 $1.4 Million
Q2 2020 Aug 07, 2020	BUY	$6.21 - $11.83 $326,192 - $621,394	52,527 New	52,527 $471,000
Q2 2019 Aug 09, 2019	SELL	$8.75 - $13.03 $90,930 - $135,407	-10,392 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$7.72 - $12.81 $496,249 - $823,439	-64,281 Reduced 86.08%	10,392 $99,000
Q4 2018 Feb 13, 2019	BUY	$9.51 - $16.6 $710,140 - $1.24 Million	74,673 New	74,673 $857,000
Q2 2018 Aug 07, 2018	SELL	$13.9 - $19.8 $387,281 - $551,667	-27,862 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$16.7 - $26.35 $34,602 - $54,597	2,072 Added 8.03%	27,862 $529,000
Q4 2017 Feb 09, 2018	BUY	$11.6 - $17.35 $299,164 - $447,456	25,790	25,790 $423,000

111

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $180M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.